Piloting MOL intervention for neuroleptic decision making
Research type
Research Study
Full title
A pilot study to assess the feasibility and acceptability of a novel intervention to help people think about their neuroleptic medication use.
IRAS ID
238098
Contact name
Sara Tai
Contact email
Sponsor organisation
University of Manchester
Clinicaltrials.gov Identifier
Duration of Study in the UK
1 years, 7 months, 30 days
Research summary
Psychosis means that a person has unusual experiences. For example, hearing, seeing or believing things that other people do not. This is usually treated with medications called neuroleptics. Some people find this medication helpful, but many do not and would like to stop taking them.
UK Health Care Policies state that the decision to stop taking medication should be shared between an individual patient and the care team providing their treatment. However, shared decision making does not happen as much in mental health services as it does in physical health care. Subsequently, a lot of mental health service users stop taking medication without telling their care team. Stopping the medication suddenly can have serious negative effects on a person's physical and mental health. This means it is important that a person's decision about their medication is supported and withdrawal occurs appropriately.
There are no established current study plans to try a new intervention to help people to think about their medication use. The intervention uses a Method of Levels therapy approach and aims to help people think about how medication fits with their life goals.
The researcher will meet with 6-12 people who are under the care of Early Intervention Services for Psychosis and who are unsure about their medication use. The participants will be able to pick when and how often (up to a maximum of 6) they want to have the therapy sessions (within a 3-month window).
As this is a new therapy approach the study plans to see if it is possible to offer the intervention in an Early Intervention Service and if people find it helpful.
REC name
North West - Greater Manchester West Research Ethics Committee
REC reference
18/NW/0411
Date of REC Opinion
11 Jun 2018
REC opinion
Favourable Opinion